News Center

November 30, 2023

Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders

FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023

Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint

FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
July 28, 2023

PGx testing informs clinical management for cancer patients

Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...
July 7, 2023

Company Spotlight Series: Greice Krautz-Peterson

Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...
July 5, 2023

Variantyx updates secondary findings reporting policy to ACMG v3.2

Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...
April 26, 2023

Company Spotlight Series: Daniel Avinoam

Meet Daniel Avinoam, Laboratory Operations Automation Specialist at Variantyx! Shortly after joining I was promoted to the operations team, where...
April 5, 2023

Variantyx welcomes two new Novaseq XPlus sequencers

Today we officially welcomed two new Illumina Novaseq XPlus sequencers with a company-wide ribbon cutting ceremony. We can’t wait to complete validation (already under way!)…